Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Nexentis Technologies's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was -25.54%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Nexentis Technologies's 5-Year ROIIC % or its related term are showing as below:
STU:80W0's 5-Year ROIIC % is ranked worse than 88.8% of 241
companies
in the Agriculture industry
Industry Median: 3.62
vs STU:80W0: -25.54
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Nexentis Technologies 5-Year ROIIC % Related Terms
Nexentis Technologies 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Nexentis Technologies's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:80W0 vs PUBC, ENFY, GNVR: 5-Year ROIIC % Comparison
For the Agricultural Inputs subindustry, Nexentis Technologies's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexentis Technologies 5-Year ROIIC % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nexentis Technologies's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Nexentis Technologies's 5-Year ROIIC % falls into.
Nexentis Technologies's 5-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -4.5605433 (Dec. 2025) - -1.109 (Dec. 2020) )
/
( 13.666 (Dec. 2025) - 0.314 (Dec. 2020) )
=
-3.4515433
/
13.352
=
-25.85%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Nexentis Technologies (STU:80W0) has a 5-Year ROIIC % of -25.54 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Nexentis Technologies and its competitors. According to the industry distribution chart, Nexentis Technologies ranks #214 out of 241 companies in the Agriculture industry, placing it in the top 88.8%.
Is Nexentis Technologies' 5-Year ROIIC % too high?
Nexentis Technologies' current 5-Year ROIIC % is -25.54. Based on the distribution chart, Nexentis Technologies ranks #214 out of 241 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Nexentis Technologies has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Nexentis Technologies' 5-Year ROIIC % compare to PUBC and ENFY?
According to the Agriculture industry distribution chart, Nexentis Technologies ranks #214 out of 241 companies for 5-Year ROIIC %. This places Nexentis Technologies in the lower half of its industry. The industry median 5-Year ROIIC % is 3.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for an Agriculture company?
The median 5-Year ROIIC % among Agriculture companies is 3.62, based on 241 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Nexentis Technologies and its competitors. For the Agriculture industry, the median 5-Year ROIIC % is 3.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexentis Technologies's current 5-Year ROIIC % is -25.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexentis Technologies stock overvalued right now?
Nexentis Technologies (STU:80W0) has a current 5-Year ROIIC % of -25.54. The stock's GF Value™ is €1,600.26, compared to a current price of €890.09 — trading 44.4% below its estimated fair value. The current 5-Year ROIIC % is -25.54. Nexentis Technologies' overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Nexentis Technologies (STU:80W0), the current 5-Year ROIIC % is -25.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexentis Technologies (STU:80W0) Overvalued in 2026?
Based on GuruFocus' analysis, Nexentis Technologies stock appears to be undervalued.
The current stock price of €890.09 is trading 44.4% below its estimated GF Value™ of €1,600.26.
Key valuation signals for STU:80W0:
5-Year ROIIC %: -25.54
GF Value™: €1,600.26 vs. price of €890.09 (44.4% below fair value)
No single metric tells the full story. See the STU:80W0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
44GF Score
Get the complete analysis for STU:80W0
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:80W0 has been successfully added to your 
